Hepion Pharmaceuticals Inc (NASDAQ:HEPA)

1.16
Delayed Data
As of Jan 14
 -0.01 / -0.85%
Today’s Change
1.12
Today|||52-Week Range
3.18
+1.75%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +331.03% increase from the last price of 1.16.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.20
Sales
$0.00
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.76%
 
 
 
 
 
 
Growthannually 81.18%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.